These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38215035)
41. Prognostic factors for small cell neuroendocrine carcinoma of the uterine cervix: an institutional experience. Intaraphet S; Kasatpibal N; Siriaunkgul S; Chandacham A; Sukpan K; Patumanond J Int J Gynecol Cancer; 2014 Feb; 24(2):272-9. PubMed ID: 24401981 [TBL] [Abstract][Full Text] [Related]
42. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341 [TBL] [Abstract][Full Text] [Related]
43. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [TBL] [Abstract][Full Text] [Related]
44. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
45. Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study. Saatli B; Olgan S; Gorken IB; Uslu T; Saygili U; Dicle N; Cingillioglu B; Gumurdulu D; Guzel AB; Koyuncuoglu M Arch Gynecol Obstet; 2014 Jun; 289(6):1331-5. PubMed ID: 24435497 [TBL] [Abstract][Full Text] [Related]
46. A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery. Fan N; Wang Z; Huang Y; Tan Z; Yang H; Lin P Cancer Control; 2021; 28():10732748211027147. PubMed ID: 34155924 [TBL] [Abstract][Full Text] [Related]
47. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response. Resende U; Cabello C; Ramalho SOB; Zeferino LC BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353 [TBL] [Abstract][Full Text] [Related]
48. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800 [TBL] [Abstract][Full Text] [Related]
49. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432 [TBL] [Abstract][Full Text] [Related]
50. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906 [TBL] [Abstract][Full Text] [Related]
51. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis. Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937 [TBL] [Abstract][Full Text] [Related]
52. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related]
53. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561 [TBL] [Abstract][Full Text] [Related]
54. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10). Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605 [TBL] [Abstract][Full Text] [Related]
55. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery. Fan X; Wang Y; Yang N; Zhu P World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912 [TBL] [Abstract][Full Text] [Related]
56. The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer. Dicu-Andreescu IG; Marincaș MA; Prunoiu VM; Dicu-Andreescu I; Ionescu SO; Simionescu AA; Brătucu E; Simion L Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138250 [No Abstract] [Full Text] [Related]
57. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy. Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336 [TBL] [Abstract][Full Text] [Related]
58. Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer. Kwon J; Eom KY; Kim IA; Kim JS; Kim YB; No JH; Kim K Cancer Res Treat; 2016 Apr; 48(2):632-40. PubMed ID: 26194370 [TBL] [Abstract][Full Text] [Related]
59. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806 [TBL] [Abstract][Full Text] [Related]
60. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]